Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.
But brand posted it up regarding Synairgen?
Is there a possibility that Gates could have been so impressed by Synairgen’s scientific team and CEO Marsden that he could choose to buy them out? Maybe as brand suggests, Gates is an avid fan of Synairgen and was very impressed by our deep dive data as well as the management of the company?
spacman was touting a potential SPAC merger later this week.
If we put 2 together, maybe Gates is overseeing the new SPAC merger which will bring Synairgen to the Nasdaq? Spacman’s post received lots of likes on this forum so that would indicate that members believe that Synairgen are going to merge with a SPAC and join the Nasdaq.
Just a bit of positivity for this tiny British biotech company, after failing to bring a single drug to market in the last 20 years there might be a ray of light
With brands brilliant bill gates post, it’s clear that Synairgen must be on bill gates radar.
Maybe bill gates is either thinking of buying synairgen? A buy out for a billion dollars perhaps?
Or bill gates and Jamie Dimon are personally overseeing the SPAC merger for the new NASDAQ listing of Synairgen because they’ve been so impressed by Marsden working at haste for the last year?
What happened to STRIVE?
Now we’re talking about merger with a $20 billion SPAC and listing on the NASDAQ???
Eh? Synairgen doesn’t even have an approved drug in twenty years or even a single drug on a trial.
But people are talking about a $20 billion SPAC merger.
Keep going, keep on dreaming
Sparky, the point is that someone earlier wrote that Synairgen could merge with a SPAC in the US on the NASDAQ.
It’s this type of ridiculous ramping from rats on here that is designed to draw in unsuspecting investors.
So it is important to tell the truth:
Synairgen is a university spin off with one single unapproved drug that it has failed to bring to market in twenty years.
Normally if a company has failed to bring a product to market in twenty years they would either go bust, or they would change management or try something different.
Many people on this board seem to think that the same people who have failed to bring anything to market in the last twenty years are somehow going to get somewhere now.
Even despite the share price crashing 90% and down to 12p, they still are clutching on to this ridiculous idea that Marsden will steer this company to market.
It’s not happening. When will the realisation finally kick in? Marsden is a horrendous CEO, he barely communicates with his shareholders and combined with Monk who oversaw the biggest calamity and embarrassment in biotech of 2022, the pair of them have failed for the last twenty years.
It’s not happening, rampers should stop trying to trick people to invest in this stock and go out and get a proper job.
Doc83, you wrote this:
Can you imagine if there was a massive leak of personal data from LSE and Andybe4’s personal details and location were disclosed… now that’d be fun!
why would that be fun?
You love Synairgen. You live it, you breath it, you ramp it. You think that it’s some kind of special company. When the reality is that it is a failed biotech company that has gone down 90% in price.
I keep making these posts so that people do not get tricked in to buying this share with the professional rampers that are on this message board.
Brook, the ‘communications director’ at Synairgen has done absolutely nothing, what comms are there? Nothing is being communicated at all. So it really would not surprise me if there are a few of you on the payroll on certain boards trying to ramp this stock for unsuspecting investors.
I repeat, it is a biotech company without a single approved drug in 20 years. It has one drug and is begging for a trial to be put on because it can’t fund its own trial. Pathetic.
The same people on here who keep on ramping this failure are the people like you doc, saying ‘wouldn’t it be funny if my location was leaked’.
So I ask, why? Would you use violence against me?
This is an anonymous internet message board, you take it so personal, this is your beloved Synairgen which appears to be heading straight down in to the gutter.
Anyway, don’t worry, Marsden is ‘working at haste’ to find a free trial for you to go on.
By the way, how many free trials are handed out to biotech company’s these days?
Or maybe there might be a SPAC merger with a $20 billion US SPAC and they could merge with Synairgen (a completely unknown failed biotech company).
It’s laughable
Target price is hit once again :)
Quick question though.
Various members of this forum kept touting STRIVE.
STRIVE in May, in July, August and October.
What happened? Where is Synairgen’s free trial? It’s been a year now. A year of begging and nothing to show, instead people suggesting that Synairgen will use a reverse merger with a $20 billion SPAC to list on the US market.
:-D
12p again
Totally implausible.
However nicely written.
I even suspect an element of desperation from the rampers of this stock suggesting a SPAC.
There’s one massive problem with the SPAC proposition. Firstly SPAC’s are generally formed with US companies. Secondly there are so many other American biotech companies that would be considered before Synairgen for a SPAC merger that this suggestion is ridiculous.
Why can people on here not get this through their skulls?
Synairgen have ONE non approved drug
Synairgen have ZERO trials.
There are biotech companies in the US that have MULTIPLE approved drugs and new drugs in MULTIPLE trials.
Synairgen has nothing. It has been begging for a free trial for virtually a year now. It is not a special biotech company, it is a university spin off research company that fluffed its chance and now it’s only chance is to beg for a free trial. It can’t even get it’s only product on to a free trial because the CEO Marsden is inept, he hasn’t been able to do anything with this company in 20 years.
Only the utterly delusional would think that big American SPAC’s worth $10’s billions would merge with Synairgen, a completely failed unknown British loss making research company worth £30 million.
It’s total delusion.
The SPAC would have merged with a company such as Britishvolt, not a company with no product and no funds like Synairgen, including a very strong record of failure.
Utter delusions
Always good for a laugh
This is the new one ‘The respiratory drug industry is worth tens of billions’ lol :-D
Yep it is, but Synairgen will not be getting any of it until their single asset gets on to a trial and passes the trial.
A biotech company with a single asset, a failed trial, zero current trials for their single asset, zero communication of any potential trials and a cash runway that is not enough to fund a trial.
Look what happened to British Volt earlier this week. They were a lot higher profile than Synairgen.
13p today
Potential investors beware, remember that this drug can ONLY come to market if it passes a successful phase 3 trial. So far it has failed a phase 3 trial due to the ineptitude and most schoolboy errors by the science team and organisers.
The company have been working at haste for 11 months to find a free trial to be put on, thus far they have failed to get their single asset on to a free trial.
Tik tok, tik tok, soon enough the cash runway stops
When that happens = fund raise or bust.
Working at haste for the last 11 months to get on a free trial.
Let’s be honest, if they don’t get on a free trial then they’re utterly f11cked.
They either just survive on their cash runway until it ends, or they do a fund raise.
It’s very rare for a biotech company to not even have a single drug on a clinical trial for a year. Synairgen mad zealots will always hype up this rubbish, until there is a trial announced the company are a total waste of time.
What’s the point of investing in a biotech company if they don’t even have a drug in any trials and can’t fund a trial themselves.
Britishvolt collapsed today.
A company with far more investment than Synairgen had.
Synairgen have had 11 months of begging governments and companies to finance a trial for them, thus far zero news. It’s not happening.
Their only hope is to have a fund raise, the SP will go down very low.
Either fund raise OR simply carry on pretending to ‘search for platform trials at haste’ whilst using up the cash runway until it finishes, then end up like Britishvolt.
It’s been said time and time again, but the beloved zealots on here can’t get it through their thick skulls.
Without a trial = no approved drug.
Without an approved drug = no money or business.
It’s been almost a year now. No other biotech company I know has sat on their fingers for an entire year without a single drug being on a trial. Absolute calamity.
Wigster, there is no chunk of sales for synairgen because they don’t have a drug that is approved.
Not only do they not have an approved drug, they don’t even have a single drug on a trial.
They don’t have enough money to fund a trial.
They have been begging governments and companies to finance a trial for them, but have failed to get anyone in the last 11 months.
Whilst Synairgen do not have an approvals drug, there is zero chance of any sales.
Looking at the trends, Synairgen has had its bounce and is now on decline for the next week. It should hit a lower dip than the previous one at 12p. Hold out until next Thursday and buy in for the bounce.
Sell on the next rise.
The decline will continue until either fund raise or trial is announced.
Fund raise = going down big time
Free trial = going up big time
You pays yer money and yer take yas chances
Similarly to when the army of zealot rampers were on here screaming ‘He wants to buy your cheap shares, he wants to buy your cheap shares’, subsequently since they lost 90% of their investment after the calamity phase 3 trial they have disappeared.
You now have similar types of people on here ramping up this rubbish company. They mention the science, they mention some journal entry about interferons, they mention a clinical trial going on in another country that has nothing to do with Synairgen etc.
It is very important to realise what will make this share move up:
1. Synairgen need to get their single asset on to a trial.
They can do that by having a fund raise which is the most likely form of financing a trial, 90% of biotech companies go down this route and Synairgen have done so in the past.
Or there is a very minimal chance they might get put on a free government run trial, such as the ACTIV trial. The problem with this is that there aren’t any government run trials going on for covid drugs because there are already lots of vaccines and anti viral medications against it. Marsden the CEO has been trying to get Synairgen on a free trial for the last 11 months and has failed. What does that tell you? There ain’t a free trial for them to get on.
90% chance a fund raise is coming in order for Synairgen to finance a new phase 3 trial.
With a fund raise the SP will fall because the shares will be diluted massively.
1. Trial is everything.
2. SP will just be day trader debris until a trial is announced.
3. 90% chance Synairgen must fund their own trial.
4. 10% chance Synairgen get on a free trial.
That gives 90% chance the SP will keep going down and especially down when the fund raise is announced.
10% chance (or less, given he’s been trying for 11 months so far with zero success) that you’ll get a multiple return.
So if you invest now, there’s 90% chance you’ll lose a good proportion of your money. Only 10% chance you’ll make money.
The smart choice would be to wait until the fund raise, the SP goes to 5p and then invest.
Has Marsden announced that their single drug and only ever possible way of making profit is on a new trial yet?
Where’s the pontiff? Marsden should have answers.
The company have a single research drug, one would presume that after a year they would make a trial for their single potential asset? Other biotech companies are putting new drugs on trials multiple times per year.
SYGGF is up 63% on our markets today
It has rebounded from last weeks disaster.
2023 is make or break for Synairgen as a company.
SPRINTER was all about turning Synairgen in to a profit making company. But 2023 will determine whether Synairgen exist as a company or not
Will they get on a free trial, despite being unable to get on a free trial in the last 11 months of Marsden ‘working at haste’?
Or will it be time for the fund raise in order to keep the company afloat?
Interestingly do people believe that a fund raise will enable Synairgen to fund their own P3 trial, or will a fund raise only generate a few million £ to keep the nice sexy wages of the workers afloat for the next couple of years before retirement?
What do you think the price will be after the next fund raise is announced?
Marsden and the rest will want to keep their jobs and income secure, so the fund raise is inevitable, how low will the price drop in 2023 when the fund raise is announced?
I predict 4-5p, and what do you predict?
Prof, they just don’t get it
:-D
Who is right and who is wrong?
When Christopher Columbus said the earth was round, everyone said he was wrong.
The Synairgen zealots have lost everything. I lost too, but sold at 40p. Now it’s 12p.
Soon it will be below 5p, but they won’t listen :-D
Then when it is below 5p, I will make a post about the rampers on here who said there was going to be a free trial, but I called BS, that Synairgen was heading fund raise.
Then when I make that post again, at 5p, they will all rush in and start using ad hominem attacks.
:-D it doesn’t matter now, Synairgen are set for fund raise in 2023 and the SP to go down to 5p or below.
You’ve been told ;)
gunto hahahahaha
This company is a pile of total sh1111111te
:-D
STRIVE? Free platform trial? Free government trial?
Even dunk bought in at 12.3p today in his own post
Hahahahha you lil beauty, have a Christmas kiss my son, now go and spend time with your family, this turkey has been blown
5p next target price when the fund raise is announced